Cargando…

Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer

BACKGROUND: The importance of immuno-histological detection of neuroendocrine differentiation in prostatic adenocarcinoma with respect to disease at presentation and Gleason grade is gaining acceptance. There is limited literature on the relative significance of three commonly used markers of NE dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Ather, M Hammad, Abbas, Farhat, Faruqui, Nuzhat, Israr, Mohammad, Pervez, Shahid
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628675/
https://www.ncbi.nlm.nih.gov/pubmed/19115997
http://dx.doi.org/10.1186/1471-2490-8-21
_version_ 1782163722580525056
author Ather, M Hammad
Abbas, Farhat
Faruqui, Nuzhat
Israr, Mohammad
Pervez, Shahid
author_facet Ather, M Hammad
Abbas, Farhat
Faruqui, Nuzhat
Israr, Mohammad
Pervez, Shahid
author_sort Ather, M Hammad
collection PubMed
description BACKGROUND: The importance of immuno-histological detection of neuroendocrine differentiation in prostatic adenocarcinoma with respect to disease at presentation and Gleason grade is gaining acceptance. There is limited literature on the relative significance of three commonly used markers of NE differentiation i.e. Chromogranin A (CgA), Neuron specific enolase (NSE) and Synaptophysin (Syn). In the current work we have assessed the correlation of immuno-histological detection of neuroendocrine differentiation in prostatic adenocarcinoma with respect to disease at presentation and Gleason grade and to determine the relative value of various markers. MATERIALS AND METHODS: Consecutive samples of malignant prostatic specimens (Transurethral resection of prostate or radical retropubic prostatectomy) from 84 patients between January 1991 and December 1998 were evaluated by immunohistochemical staining (PAP technique) using selected neuroendocrine tumor markers i.e. Chromogranin A (CgA), Neuron specific enolase (NSE), and Synaptophysin (Syn). According to the stage at diagnosis, patients were divided into three groups. Group (i) included patients who had organ confined disease, group (ii) included patients with locally invasive disease, and group (iii) with distant metastasis. NE expression was correlated with Gleason sum and clinical stage at presentation and analyzed using Chi-Square test and one way ANNOVA. RESULTS: The mean age of the patients was 70 ± 9.2 years. Group I had 14 patients, group II had 31 patients and group III had 39 patients. CgA was detected in 33 cases, Syn in 8 cases, and NSE in 44 cases. Expression of CgA was seen in 7% of group I, 37% in group II and 35% of group III patients (p 0.059). CgA (p 0.024) and NSE (p 0.006) had a significantly higher expression with worsening Gleason grade. CONCLUSION: CgA has a better correlation with disease at presentation than other markers used. Both NSE and CgA had increasing expression with worsening histological grade this correlation has a potential for use as a prognostic indicator. Limitations in the current work included small number and retrospective nature of work. The findings of this work needs validation in a larger cohort.
format Text
id pubmed-2628675
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26286752009-01-20 Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer Ather, M Hammad Abbas, Farhat Faruqui, Nuzhat Israr, Mohammad Pervez, Shahid BMC Urol Research Article BACKGROUND: The importance of immuno-histological detection of neuroendocrine differentiation in prostatic adenocarcinoma with respect to disease at presentation and Gleason grade is gaining acceptance. There is limited literature on the relative significance of three commonly used markers of NE differentiation i.e. Chromogranin A (CgA), Neuron specific enolase (NSE) and Synaptophysin (Syn). In the current work we have assessed the correlation of immuno-histological detection of neuroendocrine differentiation in prostatic adenocarcinoma with respect to disease at presentation and Gleason grade and to determine the relative value of various markers. MATERIALS AND METHODS: Consecutive samples of malignant prostatic specimens (Transurethral resection of prostate or radical retropubic prostatectomy) from 84 patients between January 1991 and December 1998 were evaluated by immunohistochemical staining (PAP technique) using selected neuroendocrine tumor markers i.e. Chromogranin A (CgA), Neuron specific enolase (NSE), and Synaptophysin (Syn). According to the stage at diagnosis, patients were divided into three groups. Group (i) included patients who had organ confined disease, group (ii) included patients with locally invasive disease, and group (iii) with distant metastasis. NE expression was correlated with Gleason sum and clinical stage at presentation and analyzed using Chi-Square test and one way ANNOVA. RESULTS: The mean age of the patients was 70 ± 9.2 years. Group I had 14 patients, group II had 31 patients and group III had 39 patients. CgA was detected in 33 cases, Syn in 8 cases, and NSE in 44 cases. Expression of CgA was seen in 7% of group I, 37% in group II and 35% of group III patients (p 0.059). CgA (p 0.024) and NSE (p 0.006) had a significantly higher expression with worsening Gleason grade. CONCLUSION: CgA has a better correlation with disease at presentation than other markers used. Both NSE and CgA had increasing expression with worsening histological grade this correlation has a potential for use as a prognostic indicator. Limitations in the current work included small number and retrospective nature of work. The findings of this work needs validation in a larger cohort. BioMed Central 2008-12-30 /pmc/articles/PMC2628675/ /pubmed/19115997 http://dx.doi.org/10.1186/1471-2490-8-21 Text en Copyright © 2008 Ather et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ather, M Hammad
Abbas, Farhat
Faruqui, Nuzhat
Israr, Mohammad
Pervez, Shahid
Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer
title Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer
title_full Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer
title_fullStr Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer
title_full_unstemmed Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer
title_short Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer
title_sort correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628675/
https://www.ncbi.nlm.nih.gov/pubmed/19115997
http://dx.doi.org/10.1186/1471-2490-8-21
work_keys_str_mv AT athermhammad correlationofthreeimmunohistochemicallydetectedmarkersofneuroendocrinedifferentiationwithclinicalpredictorsofdiseaseprogressioninprostatecancer
AT abbasfarhat correlationofthreeimmunohistochemicallydetectedmarkersofneuroendocrinedifferentiationwithclinicalpredictorsofdiseaseprogressioninprostatecancer
AT faruquinuzhat correlationofthreeimmunohistochemicallydetectedmarkersofneuroendocrinedifferentiationwithclinicalpredictorsofdiseaseprogressioninprostatecancer
AT israrmohammad correlationofthreeimmunohistochemicallydetectedmarkersofneuroendocrinedifferentiationwithclinicalpredictorsofdiseaseprogressioninprostatecancer
AT pervezshahid correlationofthreeimmunohistochemicallydetectedmarkersofneuroendocrinedifferentiationwithclinicalpredictorsofdiseaseprogressioninprostatecancer